Cato Jacobs

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1

Nico Janssen, Rémy Nyga, Lore Vanderbeke et al. · Emerging infectious diseases · 2021 · 136 citations · Full text

Covid-19–associated Pulmonary Aspergillosis1, Clinical Epidemiology, Several Factors +9

Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study

Simon Feys, Samuel M. Gonçalves, Mona Khan et al. · The Lancet Respiratory Medicine · 2022 · 106 citations · Full text

Lung Inflammation, Respiratory Diseases, Covid-19-associated Pulmonary Aspergillosis +10

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

Lore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al. · Intensive Care Medicine · 2021 · 91 citations · Full text

Proof-of-concept Trial, Antifungal Agent, Ill Influenza Patients +7

Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza

Seppe Cambier, Mieke Metzemaekers, Ana Carolina de Carvalho et al. · JCI Insight · 2021 · 61 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Lung Inflammation +21

Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019

Mieke Metzemaekers, Seppe Cambier, Marfa Blanter et al. · Clinical & Translational Immunology · 2021 · 49 citations · Full text